Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 62 (6) , 2167-2175
- https://doi.org/10.1046/j.1523-1755.2002.00657.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patientsAmerican Journal of Kidney Diseases, 2002
- Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiencyKidney International, 2001
- The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin β: results from a randomized controlled multicentre trialNephrology Dialysis Transplantation, 2000
- Dialysis TherapyNew England Journal of Medicine, 1998
- Trials to assess equivalence: the importance of rigorous methodsBMJ, 1996
- Canadian Hemodialysis Morbidity StudyAmerican Journal of Kidney Diseases, 1992
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Epoetin (Recombinant Human Erythropoietin)Drugs, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986